Champions Oncology, Inc. (CSBR)
4.953
+0.11
(+2.34%)
USD |
NASDAQ |
Oct 12, 16:00
4.95
0.00 (0.00%)
After-Hours: 20:00
Champions Oncology Free Cash Flow (Quarterly) : -0.547M for July 31, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| July 31, 2026 | -0.547M |
| April 30, 2026 | -2.237M |
| January 31, 2026 | -1.376M |
| October 31, 2025 | -1.977M |
| July 31, 2025 | 0.554M |
| April 30, 2025 | 6.615M |
| January 31, 2025 | 0.448M |
| October 31, 2024 | -0.377M |
| July 31, 2024 | 0.311M |
| April 30, 2024 | -1.705M |
| January 31, 2024 | -1.045M |
| October 31, 2023 | 0.436M |
| July 31, 2023 | -4.659M |
| April 30, 2023 | -1.452M |
| January 31, 2023 | 0.819M |
| October 31, 2022 | 2.682M |
| July 31, 2022 | -0.949M |
| April 30, 2022 | 0.29M |
| January 31, 2022 | 3.852M |
| October 31, 2021 | 0.662M |
| July 31, 2021 | -0.691M |
| April 30, 2021 | -2.834M |
| January 31, 2021 | -1.068M |
| October 31, 2020 | 0.373M |
| July 31, 2020 | -1.433M |
| Date | Value |
|---|---|
| April 30, 2020 | 1.018M |
| January 31, 2020 | 0.108M |
| October 31, 2019 | 0.587M |
| July 31, 2019 | -1.028M |
| April 30, 2019 | 0.111M |
| January 31, 2019 | 1.003M |
| October 31, 2018 | -0.211M |
| July 31, 2018 | 0.125M |
| April 30, 2018 | -0.203M |
| January 31, 2018 | 0.37M |
| October 31, 2017 | 0.236M |
| July 31, 2017 | -2.858M |
| April 30, 2017 | -0.187M |
| January 31, 2017 | -0.834M |
| October 31, 2016 | -0.114M |
| July 31, 2016 | -2.471M |
| April 30, 2016 | -0.745M |
| January 31, 2016 | -0.858M |
| October 31, 2015 | -2.612M |
| July 31, 2015 | -2.572M |
| April 30, 2015 | -2.043M |
| January 31, 2015 | -2.389M |
| October 31, 2014 | -2.498M |
| July 31, 2014 | -2.821M |
| April 30, 2014 | 0.028M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Medpace Holdings, Inc. | 138.10M |
| Avantor, Inc. | 140.60M |
| Personalis, Inc. | -29.55M |
| Adaptive Biotechnologies Corp. | -7.584M |
| 10X Genomics, Inc. | 15.39M |